Get the Stockscreener App
434.78
0.66%
2.86
After Hours:
431.06
-3.72
-0.86%
Overview
News
Price History
Option Chain
Financials
Why HCA Down?
Discussions
Forecast
Dividend History
Hca Healthcare Inc stock is traded at $434.78, with a volume of 1.13M.
It is up +0.66% in the last 24 hours and down -7.86% over the past month.
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.
See More
Previous Close:
$431.92
Open:
$429.12
24h Volume:
1.13M
Relative Volume:
1.00
Market Cap:
$96.73B
Revenue:
$76.39B
Net Income/Loss:
$7.81B
P/E Ratio:
14.95
EPS:
29.0772
Net Cash Flow:
$7.93B
1W Performance:
-7.76%
1M Performance:
-7.86%
6M Performance:
-7.18%
1Y Performance:
+27.66%
1-Day Range:
$429.12
$436.97
1-Week Range:
$422.19
$479.44
52-Week Range:
$330.00
$556.52
Hca Healthcare Inc Stock (HCA) Company Profile
Name
Hca Healthcare Inc
Sector
Industry
Phone
(615) 344-9551
Address
ONE PARK PLZ, NASHVILLE, TN
Compare HCA vs THC, FMS, ENSG, UHS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HCA
Hca Healthcare Inc
|
434.78 | 96.10B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
180.10 | 15.55B | 21.31B | 2.37B | 2.53B | 15.49 |
FMS
Fresenius Medical Care Ag Adr
|
22.16 | 12.30B | 22.18B | 1.36B | 2.00B | 1.9216 |
ENSG
Ensign Group Inc
|
186.40 | 11.00B | 5.06B | 344.26M | 370.71M | 5.8446 |
UHS
Universal Health Services Inc
|
167.97 | 9.92B | 17.36B | 1.51B | 849.25M | 23.15 |
Hca Healthcare Inc Stock (HCA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-15-25 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-14-25 | Resumed | Goldman | Buy |
| Jul-28-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-16-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-29-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Apr-15-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Dec-17-24 | Resumed | JP Morgan | Neutral |
| Nov-25-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Nov-22-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-03-24 | Initiated | Morgan Stanley | Equal-Weight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Jan-04-24 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-11-23 | Downgrade | Goldman | Buy → Neutral |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-19-23 | Resumed | JP Morgan | Neutral |
| Jul-06-22 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-29-22 | Initiated | Wells Fargo | Equal Weight |
| Jan-10-22 | Resumed | Citigroup | Buy |
| Dec-21-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-24-21 | Initiated | UBS | Buy |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Aug-12-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Jul-09-21 | Initiated | Seaport Global Securities | Buy |
| May-13-21 | Resumed | Citigroup | Neutral |
| Apr-26-21 | Downgrade | Citigroup | Buy → Neutral |
| Dec-15-20 | Initiated | Goldman | Buy |
| Dec-14-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Sep-21-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-13-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Sep-06-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jul-10-19 | Upgrade | Goldman | Neutral → Buy |
| Apr-23-19 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Nov-16-18 | Initiated | UBS | Buy |
| Mar-23-18 | Resumed | Mizuho | Buy |
| Jan-03-18 | Initiated | Goldman | Neutral |
| Jan-03-18 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Dec-20-17 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Dec-12-17 | Upgrade | Citigroup | Neutral → Buy |
| Nov-30-17 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-06-17 | Reiterated | Citigroup | Neutral |
| Nov-01-17 | Reiterated | Mizuho | Buy |
| Jul-26-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-28-17 | Initiated | Argus | Buy |
View All
Hca Healthcare Inc Stock (HCA) Latest News
HCA Healthcare (NYSE: HCA) lifts Q1 2026 revenue and EPS to $7.15 - Stock Titan
Is HCA Healthcare Stock Undervalued Stock Or Value Trap? - Trefis
HCA Healthcare, Inc. $HCA Shares Purchased by Narwhal Capital Management - MarketBeat
Pictet Asset Management Holding SA Sells 16,605 Shares of HCA Healthcare, Inc. $HCA - MarketBeat
Mitsubishi UFJ Trust & Banking Corp Has $40.27 Million Holdings in HCA Healthcare, Inc. $HCA - MarketBeat
Comerica Bank Sells 3,248 Shares of HCA Healthcare, Inc. $HCA - MarketBeat
This Week's Healthcare Earnings: Elevance, HCA And More - Law360
HCA Healthcare Stockholders Reaffirm Board and Governance Structure - TipRanks
HCA Healthcare Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
HCA Healthcare (HCA) shareholders elect directors, back pay plan, reject proposals - Stock Titan
HCA Healthcare Inc Stock (HCA) Closed Down by 3.23% on Apr 28: Drivers Behind the Movement - TradingKey
Congress grills hospital CEOs over costs - Modern Healthcare
HCA Healthcare beats quarterly profit estimates on medical care demand - MSN
HCA Healthcare Inc. stock underperforms Friday when compared to competitors - MSN
Bernstein SocGen cuts HCA Healthcare price target on weather headwinds - Investing.com
Sanford C. Bernstein Lowers HCA Healthcare (NYSE:HCA) Price Target to $503.00 - MarketBeat
Deutsche Bank Aktiengesellschaft Has Lowered Expectations for HCA Healthcare (NYSE:HCA) Stock Price - MarketBeat
Deutsche Bank Adjusts HCA Healthcare Price Target to $540 From $558, Maintains Buy Rating - marketscreener.com
HCA DCF Analysis: Intrinsic Value $765 vs Price $446 - GuruFocus
HCA Healthcare prices senior notes offering of up to $3 billionfiling - marketscreener.com
Bernstein Adjusts Price Target on HCA Healthcare to $503 From $541, Maintains Market Perform Rating - marketscreener.com
State of Michigan Retirement System Has $19.52 Million Stake in HCA Healthcare, Inc. $HCA - MarketBeat
HCA Healthcare, Inc. $HCA Stock Holdings Lifted by Advisors Capital Management LLC - MarketBeat
HCA Healthcare Launches Note Offering to Refinance 2026 Debt - TipRanks
HCA Healthcare Inc (HCA) Stock Price, Trades & News - GuruFocus
HCA Healthcare Q1 Earnings Call Highlights - MarketBeat
HCA Healthcare names Cynthia Cifuentes-Finkel marketing chief - Investing.com
HCA Healthcare Names Cynthia Cifuentes-Finkel Senior Vice President of Marketing and Corporate Affairs - Business Wire
HCA (NYSE: HCA) plans senior notes sale to redeem 2026 issues - Stock Titan
HCA Healthcare Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
HCA Healthcare Q3 2025 Earnings Preview - MSN
HCA Healthcare hospitals earn 26 Press Ganey Human Experience Awards for patient experience - HCA Healthcare Today
How The Investment Story For HCA Healthcare (HCA) Is Shifting Around AI And Medicaid Assumptions - Yahoo Finance
HCA Healthcare Market Update: Index Signals Shape Healthcare View - Kalkine Media
HCA Healthcare Pressure Expected to Persist Through Q2 on Managed Care Rotation, RBC Says - marketscreener.com
HCA Maintained by TD Cowen -- Price Target Lowered to $500 - GuruFocus
HCA Healthcare Q1 2026 Earnings: Revenue $19.11B, EPS $7.15, Miss on EBITDANews and Statistics - IndexBox
These analysts slash their forecasts on HCA Healthcare after Q1 results - MSN
HCA Maintained by Barclays -- Price Target Lowered to $496 - GuruFocus
HCA Healthcare Stock Fell 9% After Q1 2026 Earnings. Was the Selloff Justified? - TIKR.com
ACA subsidy lapse cost HCA Healthcare $150M in Q1 - Healthcare Dive
HCA Maintained by Stephens & Co. -- Price Target Lowered to $530 - GuruFocus
HCA Healthcare drops despite Q1 beat as volume weakness concerns investors - MSN
HCA Maintains Overweight Rating -- Price Target Lowered to $510 - GuruFocus
HCA Maintained by Oppenheimer -- Price Target Lowered to $520 - GuruFocus
Truist cuts HCA Healthcare stock price target on weaker volumes - Investing.com
Stephens Issues Pessimistic Forecast for HCA Healthcare (NYSE:HCA) Stock Price - MarketBeat
These Analysts Slash Their Forecasts On HCA Healthcare After Q1 Results - Benzinga
TD Cowen cuts HCA Healthcare stock price target on weak respiratory volumes - Investing.com Canada
Stephens lowers HCA Healthcare stock price target on weaker volumes - Investing.com
Stephens lowers HCA Healthcare stock price target on weaker volumes By Investing.com - Investing.com Canada
Hca Healthcare Inc Stock (HCA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.46%
1.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):